Albat Remedies Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 11 Year, 11 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.00 M
- Revenue Growth -50.50%
- Profit Growth -37.65%
- Ebitda -35.97%
- Net Worth 13.64%
- Total Assets 28.83%
About Albat Remedies
Albat Remedies Limited (ARL) is a Public Limited Indian Non-Government Company incorporated in India on 23 January 2014 and has a history of 11 years. Its registered office is in Krishnagiri, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹3.00 M.
Abhijeeth Sakaria, Thanmal Kumar, and Yashwant Sakaria serve as directors at the Company.
Company Details
-
Location
Krishnagiri, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100TZ2014PLC029852
-
Company No.
029852
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
23 Jan 2014
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Coimbatore
Industry
What products or services does Albat Remedies Limited offer?
Albat Remedies Limited offers a wide range of products and services, including Surgical & ICU Equipments, Stethoscope, Physiotherapy & Rehab Aids, Medical Pillow.
Who are the key members and board of directors at Albat Remedies?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhijeeth Sakaria
|
Director | 23-Jan-2014 | Current |
|
Thanmal Kumar
|
Director | 06-Jun-2014 | Current |
|
Yashwant Sakaria
|
Director | 23-Jan-2014 | Current |
Financial Performance of Albat Remedies.
Albat Remedies Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 50.5% decrease. The company also saw a substantial fall in profitability, with a 37.65% decrease in profit. The company's net worth Soared by an impressive increase of 13.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Albat Remedies?
In 2022, Albat Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹3.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Jan 2022 | Others | ₹3.00 M | Open |
How Many Employees Work at Albat Remedies?
Unlock and access historical data on people associated with Albat Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Albat Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Albat Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
